Human Longevity
Latest round
- Series B
Last raised
- Mar 2023
Total raised
- $633M
Investors
- 10
About Human Longevity
Founded in 2013 by founder J. Craig Venter and based in California, US, Human Longevity, Inc. provides a clinical research platform that compiles and analyzes genotypic and phenotypic data to understand and generate insights that will help to accelerate ways to discover and prevent risks and signals of diseases. In August 2024, Human Longevity, Inc.26 million post-money. Human Longevity, Inc. v offers genome sequencing to analyze an individual’s genetic makeup. This information helps in assessing genetic risk factors and guiding personalized health recommendations. The company conducts detailed health evaluations that include diagnostic tests to identify potential health issues and develop personalized health management plans. The diagnostic tests include coronary calcium scoring, advanced blood tests, echocardiograms, electrocardiograms, exercise stress tests, and insulin sensitivity testing. These tests help in assessing cardiovascular health, metabolic function, and other health parameters. Additionally, the firm uses wearable technology to track daily health metrics, such as glucose levels and sleep patterns. This continuous monitoring helps refine health recommendations and interventions.
Who invested in Human Longevity
10 investors across 5 rounds
See all investors in Human Longevity
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Human Longevity
Who invested in Human Longevity?
Human Longevity has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Human Longevity raised?
Human Longevity has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Human Longevity last raise money?
Human Longevity's most recent round on record is a Series B, in Mar 2023.
What does Human Longevity do?
Human Longevity is a biotechnology company.
Where is Human Longevity headquartered?
Human Longevity is headquartered in San Diego, US.
Which VCs invest in companies like Human Longevity?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Human Longevity's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Human Longevity? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.